News

The acquisition is subject to Abviva’s due diligence, final approval by Abviva’s board of directors and entry of an order approving the sale by the court. Genesis Bioventures

The Phase III study evaluated the efficacy of iloperidone versus placebo in patients with schizophrenia. The study was a randomized, double-blind, placebo-controlled, multi-center, four-week inpatient study that enrolled

Zimmer said that a key strength of its mobile bearing system is its ability to be used in a minimally invasive procedure – the LPS-Flex mobile knee is

The new products, to be marketed under the brand name CellPrime, will be manufactured by Novozymes and sold through Millipore’s sales organization. The alliance expands the existing relationship

With a target of 56 patients, the five sites participating in the trial have now enrolled 59 patients. The company said that given the small patient numbers in

Copernicus has earned the milestone payment by demonstrating a significant improvement in the level of CFTR gene activity in an animal model. This increased improvement in the level

The product is under development for the prevention of hepatitis C virus (HCV) re-infection after liver transplantation. As an outcome of its E1 research program, Genimmune has identified

With a standard titration regimen, the trial met its primary objective with sustained and statistically significant reduction in average daily pain scores. The trial in 551 patients with

The acquisition is expected to be implemented by way of a court approved scheme of arrangement, whereby BBI would become a wholly owned subsidiary of Inverness Medical. The